Dicerna Pharmaceuticals
DRNA
#4068
Rank
NZ$4.91 B
Marketcap
NZ$63.11
Share price
0.00%
Change (1 day)
16,099.03%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: NZ$4.91 Billion

As of February 2026 Dicerna Pharmaceuticals has a market cap of NZ$4.91 Billion. This makes Dicerna Pharmaceuticals the world's 4068th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$4.69 B7.58%
2021NZ$4.35 B88.48%
2020NZ$2.31 B-1.2%
2019NZ$2.34 B115.37%
2018NZ$1.08 B65.56%
2017NZ$0.65 B660.98%
2016NZ$86.28 M-75.84%
2015NZ$0.35 B-4.47%
2014NZ$0.37 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$253.93 B 5,065.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$334.45 B 6,702.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$485.19 B 9,768.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.93 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$69.80 B 1,319.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$14.48 B 194.58%๐Ÿ‡บ๐Ÿ‡ธ USA